1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HADHB mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of HADHB mRNA CTD PMID:22206623 1,3-dinitrobenzene increases oxidation ISO RGD:620513 6480464 3-dinitrobenzene results in increased oxidation of HADHB protein CTD PMID:25716674 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of HADHB mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:736480 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of HADHB mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HADHB mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HADHB mRNA CTD PMID:20702594 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620513 6480464 Tetrachlorodibenzodioxin results in decreased expression of HADHB mRNA CTD PMID:21215274 2,3,7,8-Tetrachlorodibenzofuran affects expression EXP 6480464 2 more ... CTD PMID:20702594 2,6-dinitrotoluene affects expression ISO RGD:620513 6480464 2, 6-dinitrotoluene affects the expression of HADHB mRNA CTD PMID:21346803 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of HADHB mRNA, [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of HADHB mRNA CTD PMID:23428407 , PMID:24848799 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of HADHB mRNA CTD PMID:18648102 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:736480 6480464 [6-4-chlorophenylimidazo2 more ... CTD PMID:30611723 acetamide decreases expression ISO RGD:620513 6480464 acetamide results in decreased expression of HADHB mRNA CTD PMID:31881176 ammonium chloride affects expression ISO RGD:620513 6480464 Ammonium Chloride affects the expression of HADHB mRNA CTD PMID:16483693 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of HADHB mRNA CTD PMID:23650126 aspartame multiple interactions EXP 6480464 [Fats more ... CTD PMID:23783067 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzoapyrene affects the expression of HADHB mRNA] CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:736480 6480464 Benzoapyrene affects the methylation of HADHB 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of HADHB mRNA CTD PMID:22228805 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of HADHB mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of HADHB mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:620513 6480464 Diethylhexyl Phthalate results in increased expression of HADHB mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of HADHB mRNA CTD PMID:19850644 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HADHB mRNA CTD PMID:30566610 buspirone increases expression ISO RGD:620513 6480464 Buspirone results in increased expression of HADHB mRNA CTD PMID:24136188 cadmium atom increases oxidation EXP 6480464 Cadmium results in increased oxidation of HADHB protein CTD PMID:24496640 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of HADHB mRNA CTD PMID:25620056 ciprofibrate increases expression ISO RGD:620513 6480464 ciprofibrate results in increased expression of HADHB mRNA CTD PMID:27225895 clofibrate increases expression ISO RGD:620513 6480464 Clofibrate results in increased expression of HADHB mRNA CTD PMID:12851107 , PMID:18670166 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of HADHB mRNA CTD PMID:23811191 clofibrate decreases expression ISO RGD:620513 6480464 Clofibrate results in decreased expression of HADHB protein CTD PMID:20118634 Clofop multiple interactions ISO RGD:736480 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of HADHB mRNA CTD PMID:16197558 copper atom decreases expression ISO RGD:620513 6480464 Copper deficiency results in decreased expression of HADHB mRNA CTD PMID:19821111 copper(0) decreases expression ISO RGD:620513 6480464 Copper deficiency results in decreased expression of HADHB mRNA CTD PMID:19821111 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of HADHB mRNA CTD PMID:19770486 dehydroepiandrosterone increases expression ISO RGD:620513 6480464 Dehydroepiandrosterone results in increased expression of HADHB mRNA CTD PMID:16940010 dexamethasone multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of HADHB mRNA, [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of HADHB mRNA CTD PMID:23428407 , PMID:24848799 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HADHB mRNA CTD PMID:29950665 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of HADHB mRNA CTD PMID:17361019 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of HADHB mRNA CTD PMID:28962523 dicrotophos decreases expression ISO RGD:736480 6480464 dicrotophos results in decreased expression of HADHB mRNA CTD PMID:28302478 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of HADHB mRNA CTD PMID:26873546 doxorubicin decreases expression ISO RGD:736480 6480464 Doxorubicin results in decreased expression of HADHB mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:620513 6480464 Endosulfan results in increased expression of HADHB mRNA CTD PMID:29391264 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of HADHB mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of HADHB mRNA CTD PMID:30319688 farnesol multiple interactions ISO RGD:736480 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHB mRNA CTD PMID:30611723 farnesol increases expression ISO RGD:736480 6480464 Farnesol analog results in increased expression of HADHB mRNA CTD PMID:30611723 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of HADHB mRNA CTD PMID:17118139 fenofibrate increases expression ISO RGD:736480 6480464 Fenofibrate results in increased expression of HADHB mRNA CTD PMID:24752549 , PMID:25572481 fenofibrate decreases expression ISO RGD:620513 6480464 Fenofibrate results in decreased expression of HADHB protein CTD PMID:20118634 fenofibrate affects expression ISO RGD:620513 6480464 Fenofibrate affects the expression of HADHB mRNA CTD PMID:20801182 finasteride increases expression ISO RGD:620513 6480464 Finasteride results in increased expression of HADHB mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide analog results in decreased expression of HADHB mRNA, Flutamide results in decreased expression of HADHB mRNA CTD PMID:17702527 , PMID:19442681 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HADHB mRNA CTD PMID:22206623 gentamycin decreases expression ISO RGD:620513 6480464 Gentamicins results in decreased expression of HADHB mRNA CTD PMID:22061828 GW 7647 increases expression ISO RGD:736480 6480464 GW 7647 results in increased expression of HADHB mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO RGD:736480 6480464 [GW 7647 co-treated with Oleic Acid] results in increased expression of HADHB mRNA more ... CTD PMID:30611723 lead(0) decreases expression ISO RGD:736480 6480464 Lead results in decreased expression of HADHB mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:736480 6480464 Lead results in decreased expression of HADHB mRNA CTD PMID:19921347 leflunomide increases expression ISO RGD:620513 6480464 leflunomide results in increased expression of HADHB mRNA CTD PMID:24136188 methotrexate increases expression ISO RGD:736480 6480464 Methotrexate results in increased expression of HADHB mRNA CTD PMID:17400583 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of HADHB protein CTD PMID:26984711 monosodium L-glutamate multiple interactions EXP 6480464 [Fats more ... CTD PMID:23783067 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of HADHB exon CTD PMID:17116638 nefazodone increases expression ISO RGD:620513 6480464 nefazodone results in increased expression of HADHB mRNA CTD PMID:24136188 nimesulide increases expression ISO RGD:620513 6480464 nimesulide results in increased expression of HADHB mRNA CTD PMID:24136188 ochratoxin A decreases expression ISO RGD:736480 6480464 ochratoxin A results in decreased expression of HADHB protein CTD PMID:26861962 oleic acid multiple interactions ISO RGD:736480 6480464 [6-4-chlorophenylimidazo2 more ... CTD PMID:30611723 oleic acid increases expression ISO RGD:736480 6480464 Oleic Acid results in increased expression of HADHB mRNA CTD PMID:30611723 paracetamol decreases expression ISO RGD:736480 6480464 Acetaminophen results in decreased expression of HADHB mRNA CTD PMID:22230336 perfluorobutanesulfonic acid increases expression ISO RGD:620513 6480464 perfluorobutanesulfonic acid results in increased expression of HADHB mRNA CTD PMID:22071372 perfluorobutyric acid decreases expression ISO RGD:620513 6480464 perfluorobutyric acid results in decreased expression of HADHB mRNA CTD PMID:22071372 perfluorododecanoic acid increases expression ISO RGD:620513 6480464 perfluorododecanoic acid results in increased expression of HADHB mRNA CTD PMID:22071372 perfluorohexanesulfonic acid increases expression ISO RGD:620513 6480464 perfluorohexanesulfonic acid results in increased expression of HADHB mRNA CTD PMID:22071372 perfluorohexanoic acid increases expression ISO RGD:620513 6480464 perfluorohexanoic acid results in increased expression of HADHB mRNA CTD PMID:22071372 perfluorononanoic acid increases expression ISO RGD:620513 6480464 perfluorononanoic acid results in increased expression of HADHB mRNA CTD PMID:22071372 perfluorooctane-1-sulfonic acid increases expression ISO RGD:620513 6480464 perfluorooctane sulfonic acid results in increased expression of HADHB mRNA CTD PMID:18692542 , PMID:19162173 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:620513 6480464 perfluorooctane sulfonic acid results in decreased expression of HADHB mRNA CTD PMID:22071372 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of HADHB mRNA CTD PMID:19429403 , PMID:20936131 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of HADHB mRNA] CTD PMID:20936131 perfluorooctanoic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of HADHB mRNA] CTD PMID:18467677 , PMID:20936131 perfluorooctanoic acid increases expression ISO RGD:620513 6480464 perfluorooctanoic acid results in increased expression of HADHB mRNA CTD PMID:16221955 more ... perfluorooctanoic acid increases expression ISO RGD:736480 6480464 perfluorooctanoic acid results in increased expression of HADHB mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HADHB mRNA CTD PMID:17681415 more ... perfluoroundecanoic acid increases expression ISO RGD:620513 6480464 perfluoroundecanoic acid results in increased expression of HADHB mRNA CTD PMID:22071372 phenobarbital decreases expression ISO RGD:620513 6480464 Phenobarbital results in decreased expression of HADHB mRNA CTD PMID:19162173 phlorizin increases expression EXP 6480464 Phlorhizin results in increased expression of HADHB mRNA CTD PMID:22538082 picrotoxin decreases expression ISO RGD:620513 6480464 Picrotoxin results in decreased expression of HADHB mRNA CTD PMID:15170462 pirinixic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of HADHB mRNA] CTD PMID:17950772 , PMID:18467677 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HADHB mRNA CTD PMID:15375163 more ... pirinixic acid increases expression ISO RGD:620513 6480464 pirinixic acid results in increased expression of HADHB mRNA CTD PMID:16940010 more ... pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of HADHB mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:620513 6480464 Pravastatin results in decreased expression of HADHB mRNA CTD PMID:27225895 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of HADHB mRNA CTD PMID:21278054 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of HADHB protein CTD PMID:25505154 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of HADHB mRNA CTD PMID:17702527 rotenone increases expression ISO RGD:620513 6480464 Rotenone results in increased expression of HADHB mRNA CTD PMID:28374803 SB 431542 increases expression ISO RGD:736480 6480464 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide results in increased expression of HADHB protein CTD PMID:25670856 sodium arsenite increases expression ISO RGD:620513 6480464 sodium arsenite results in increased expression of HADHB protein CTD PMID:29459688 Soman decreases expression ISO RGD:620513 6480464 Soman results in decreased expression of HADHB mRNA CTD PMID:19281266 sulforaphane increases expression EXP 6480464 sulforafan results in increased expression of HADHB mRNA CTD PMID:30529165 sulindac decreases expression ISO RGD:620513 6480464 Sulindac results in decreased expression of HADHB mRNA CTD PMID:24136188 tacrolimus hydrate decreases expression EXP 6480464 Tacrolimus results in decreased expression of HADHB mRNA CTD PMID:25270620 Tesaglitazar increases expression ISO RGD:620513 6480464 tesaglitazar results in increased expression of HADHB mRNA CTD PMID:21515302 tetrachloromethane affects expression ISO RGD:620513 6480464 Carbon Tetrachloride affects the expression of HADHB mRNA CTD PMID:15963342 , PMID:16239168 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of HADHB mRNA CTD PMID:23557971 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HADHB mRNA CTD PMID:29950665 titanium dioxide decreases expression ISO RGD:736480 6480464 titanium dioxide results in decreased expression of HADHB protein CTD PMID:30910687 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of HADHB mRNA CTD PMID:23428407 , PMID:24848799 trichloroethene increases expression ISO RGD:620513 6480464 Trichloroethylene results in increased expression of HADHB mRNA CTD PMID:27618143 trichloroethene decreases methylation ISO RGD:620513 6480464 Trichloroethylene results in decreased methylation of HADHB promoter CTD PMID:27618143 troglitazone increases expression ISO RGD:620513 6480464 troglitazone results in increased expression of HADHB mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:736480 6480464 Valproic Acid results in decreased methylation of HADHB gene CTD PMID:29154799 valproic acid increases expression ISO RGD:736480 6480464 Valproic Acid results in increased expression of HADHB mRNA CTD PMID:29501571 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HADHB mRNA CTD PMID:21427059 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of HADHB mRNA CTD PMID:17292431 vinclozolin decreases expression ISO RGD:620513 6480464 vinclozolin results in decreased expression of HADHB mRNA CTD PMID:23555832 zaragozic acid A affects expression EXP 6480464 squalestatin 1 affects the expression of HADHB mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:620513 6480464 squalestatin 1 affects the expression of HADHB mRNA CTD PMID:27225895